Shafik Boyaji, MD
Pain Medicine · Phoenix, AZNPI 1710290861
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.1% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 27 manufacturers reported payments, led by Abbott at 29.3% of the total. Reporting peaked in 2022 at $3,308 and has fallen 64.4% since, to $1,178 in 2025.
Across 241 payments — averaging $41.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$1K
- Boston Scientific$1K
- Nevro Corp.$1K
- Spinal Simplicity, LLC$994
- Globus Medical$434
- plus $2K from 21 others
What the payments were for
- Travel & lodging$7918%
- Food & beverage$9,20792%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 86 | $2,927 |
| Medtronic(2 entities) | 31 | $1,380 |
| Boston Scientific | 34 | $1,224 |
| Nevro Corp. | 18 | $1,159 |
| Spinal Simplicity, LLC | 11 | $994 |
| Globus Medical(2 entities) | 10 | $434 |
| Vertos Medical, Inc. | 2 | $265 |
| Stryker | 6 | $237 |
| SPR Therapeutics, Inc | 3 | $198 |
| Stimwave Technologies Incorporated | 1 | $180 |
| Avanos Medical | 2 | $176 |
| Spinefrontier, Inc. | 1 | $152 |
| GRT US Holding, Inc. | 5 | $111 |
| Saluda Medical Americas, Inc. | 6 | $89 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $77 |
| Nalu Medical, Inc. | 2 | $75 |
| Averitas Pharma Inc. | 3 | $70 |
| Collegium Pharmaceutical, Inc. | 3 | $47 |
| Valinor Pharma, LLC | 2 | $39 |
| Scilex Pharmaceuticals Inc. | 2 | $35 |
| Painteq LLC | 2 | $31 |
| Curonix LLC | 1 | $20 |
| Protega Pharmaceutials Inc | 1 | $18 |
| Amgen | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Biotronik NRO, Inc. | 1 | $14 |
| Biodelivery Sciences International, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,159
- HA MINUTEMAN G3-R$773
- WAVEWRITER ALPHA$414
- GENERAL PAIN MANAGEMENT$385
- mild Device Kit$265
- ETERNA$259
- KYPHON EXPRESS II KYPHOPAK TRAY$247
- Senza$224
- INTELLIS$165
- InSpan$152
- Sacrix$152
- SPRINT PNS System$149
- Proclaim IPG$149
- Omnia$145
- ACTIVOS 10 BONE CEMENT$133
- CORRIDOR$133
- SPINEJACK$126
- COOLIEF* COOLED RADIOFREQUENCY$125
- Senza Spinal Cord Stimulation System$116
How this compares
$9,998 in reported general payments places this provider in the 70th percentile of 180 pain medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 27 | $11,978 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 402 | $11,393 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 374 | $8,268 |
| Buprenorphine | 24 | $8,003 |
| Gabapentin | 768 | $7,188 |
| OxycontinOxycodone Hcl | 12 | $6,863 |
| Oxycodone Hcl | 310 | $5,605 |
| Pregabalin | 240 | $5,027 |
| Fentanyl | 52 | $3,298 |
| Celecoxib | 150 | $3,165 |
| Tizanidine Hcl | 305 | $3,129 |
| Morphine Sulfate ErMorphine Sulfate | 87 | $2,450 |
| Lidocaine | 29 | $1,977 |
| Tramadol Hcl | 233 | $1,650 |
| Duloxetine Hcl | 41 | $1,064 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $47 | $11,97827 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 180 pain medicine providers in Arizona.
Other pain medicine in Phoenix
- Minesh ZaveriPhoenix$187K
- Christine HaddadPhoenix$98K
- Gobi ParamanandamPhoenix$46K
- Omar ViswanathPhoenix$42K
- Lynn ChangPhoenix$29K
- Mark KallgrenPhoenix$24K
- Ruchir GuptaPhoenix$15K
- Shawnjeet SainiPhoenix$14K
- Jawad ArshadPhoenix$13K
- Nicholas ScottPhoenix$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.